[Click eStock] "Jinwon Life Sciences, Plasmid DNA Facility Alone Worth at Least 4 Trillion Won"

[Asia Economy Reporter Jang Hyowon] Leading Investment & Securities analyzed on the 15th that Jinwon Life Sciences' plasmid DNA production facility alone could be valued at a minimum of 4 trillion KRW.

Researcher Oh Seungtaek of Leading Investment & Securities stated, "As the gene therapy market grows, the demand for plasmid DNA, a core raw material, is surging," and added, "Jinwon Life Sciences plans to expand its production facilities tenfold by the end of this year, with expected annual sales of plasmid DNA projected to be 500 billion KRW after 2022 and over 800 billion KRW in 2023."

Researcher Oh explained, "Competitor Aldevron already raised funds in 2019 to expand its plasmid DNA production facilities and was valued at 3.4 billion USD (approximately 4 trillion KRW)."

Jinwon Life Sciences operates a contract manufacturing business for nucleic acid (mRNA, DNA)-based gene therapies and their raw material, plasmid DNA. Currently, plasmid DNA is produced through its 100% subsidiary, the US corporation VGXI, and facility expansion is underway.

Jinwon Life Sciences also possesses mRNA bulk production processes. In 2018, it acquired mRNA bulk production technology from the Methodist Hospital Research Institute in Houston, USA. With the active research on mRNA due to COVID-19, the bulk production process has also gained prominence.

He explained, "In addition, the company holds pipelines such as an acute sinusitis treatment utilizing bitter taste receptor stimulation mechanisms, the COVID-19 nasal infection prevention product GLS-1200, and the overactive immune control chemical synthetic drug GLS-1027, with technology export planned after phase 2 completion."

Furthermore, he analyzed, "Considering that the plasmid DNA production facility alone can be valued at a minimum of 4 trillion KRW, and factoring in mRNA bulk production technology and the value of ongoing pipelines, the current market capitalization of 1 trillion KRW appears to be a discounted range."

This content was produced with the assistance of AI translation services.